Summary
- Profile Type
- Technology offer
- POD Reference
- TOES20230927005
- Term of Validity
- 10 November 2023 - 9 November 2025
- Company's Country
- Spain
- Type of partnership
- Research and development cooperation agreement
- Commercial agreement with technical assistance
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- The Spanish young spin off company holds a patented technology that combines nanomechanics, optics and machine learning that allows rapid detection and characterization of cells and microorganism with high precision. The company looks for partners willing to collaborate in new health product innovations and co-developments related with health new diagnostic devices.
- Full Description
- Nanological is a spin-off of the Spanish National Research Council (CSIC), the biggest public research institution in Spain, focused on the design, development and commercialization of new pathogen identification devices. With an experienced and interdisciplinary team of physicists, biologists and data scientists,with stablished collaborations regarding biosensing clinical validation specialists the company solutions comprises, modular hardware and software components that can be interchanged for a better product and service design.
- Advantages and Innovations
- Company solutions oriented to the health diagnostic market constitue a breakthrough innovation integrating nano-optical, nanomechanical and machine learning technologies that allow accurate and quasi real time pathogens identification reducing patient risks, ameliorating response time and reducing cost and resource consumption in hospitals, clinics and related lab departments.
- Technical Specification or Expertise Sought
- Partners with experience in health innovation, diagnostic devices development, operating in health system agents (public/private) facing new innovations for current products or future developments.
- Stage of Development
- Under development
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- Goal 9: Industry, Innovation and Infrastructure
- IPR status
- IPR granted
Partner Sought
- Expected Role of a Partner
- Health innovation agents, with r&d or innovation activities related to new diagnostic devices.
- Type and Size of Partner
- R&D Institution
- SME 11-49
- Big company
- SME 50 - 249
- SME <=10
- University
- Type of partnership
- Research and development cooperation agreement
- Commercial agreement with technical assistance
Dissemination
- Technology keywords
- 005010 - Micro- and Nanotechnology related to physical sciences
- 09001007 - Optical Technology related to measurements
- 06001013 - Medical Technology / Biomedical Engineering
- 01003003 - Artificial Intelligence (AI)
- 01006009 - Signal Processing
- Market keywords
- 005001008 - Diagnostic test products and equipment
- 05001001 - Diagnostic services
- 05001002 - In-vitro diagnostics
- 05004005 - Diagnostic equipment
- 03007002 - Other measuring devices
- Sector Groups Involved
- Digital
- Health
- Electronics
- Targeted countries
- All countries